loading

Finanzdaten der Silence Therapeutics Plc Adr-Aktie (SLN)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
100.00%
-
0.422 0.034 0.159 0.224
Cost Of Revenue
100.00%
-
0.011 0.012 0.064 0.085
Gross Profit
100.00%
-
0.411 0.022 0.095 0.139
Research and Development
0.29%
9.148
9.122 - - -
Operating Income/Loss
11.90%
-13.87
-15.74 -12.46 -26.24 -23.96
Income/Loss From Continuing Operations Before Tax
17.98%
-12.27
-14.96 -11.77 -20.96 -27.34
Income Tax Expense/Benefit
0.001
- - 0.001 0.01
Net Income/Loss
17.98%
-12.27
-14.96 -11.77 -20.96 -27.35
Basic Average Shares
0.01%
141.71
141.70 0.00241 141.70 141.70
Diluted Average Shares
0.01%
141.71
141.70 0.00241 141.70 141.70
Basic Earnings Per Share
18.18%
-0.09
-0.11 -0.09 -0.15 -0.19
Diluted Earnings Per Share
18.18%
-0.09
-0.11 -0.09 -0.15 -0.19
$13.05
price up icon 0.19%
$18.20
price up icon 0.28%
$36.62
price up icon 2.35%
$12.73
price up icon 3.62%
$39.07
price up icon 6.34%
$13.12
price up icon 1.67%
Kapitalisierung:     |  Volumen (24h):